Product Code: DLB FDA class 2 21 CFR 862.3580

Radioimmunoassay, Lsd (125-I)

Clinical Toxicology

The Radioimmunoassay for LSD using iodine-125 radiolabel is a laboratory test system designed to detect and quantify lysergic acid diethylamide (LSD) in patient specimens using radioimmunoassay techniques. It is classified as Class 2, requiring a 510(k) premarket notification prior to marketing. The product code is DLB, regulated under 21 CFR 862.3580, within the Clinical Toxicology specialty. It is eligible for third-party 510(k) review.

510(k)s
7
FEI Numbers
7
Registration Numbers
7
Unique Applicants
5
Years Active
10

Research product code DLB in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
DLB
Device Class
FDA class 2
Regulation Number
862.3580
Medical Specialty
Clinical Toxicology
Review Panel
TX
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 7 510(k) clearances via K numbers.

K Number Device Name
K961436 ABUSCREEN ONLINE LSD REAGENT (90 ML TEST KIT)
K955448 EMIT II LSD ASSAY, EMIT LSD CALIBRATORS & EMIT LSD CONTROLS
K955814 CEDIA DAU LSD ASSAY
K954073 STC DIAGNOSTICS LSD MICRO-PLATE EIA
K891167 COAT-A-COUNT(TM) LSD RADIOIMMUNOASSAY KIT
K874270 REVISED LABELING FOR LSD TEST KIT
K860525 ABUSCREEN RADIOIMMUNOASSAY FOR LSD W/ REF STANDARD

FEI Numbers

This FDA classification entry is associated with 7 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 7 registration numbers. Click on an entry to view related FDA registrations.